Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 85.40
+0.23 (0.27%)
At close: Dec 1, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 19.74 billion as of December 2, 2025. Its market cap has increased by 87.10% in one year.
Market Cap
19.74B
Enterprise Value
21.63B
Revenue
13.30B
Ranking
n/a
PE Ratio
22.10
Stock Price
85.40
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 19.74B, an increase of 176.34%. That is a compound annual growth rate of 25.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 19.74B | 26.88% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
| Jul 9, 2021 | 7.14B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 127.22B |
| Abbott Laboratories (Pakistan) | 103.75B |
| The Searle Company | 60.70B |
| Highnoon Laboratories | 57.27B |
| AGP Limited | 52.41B |
| Shifa International Hospitals | 32.87B |
| Ferozsons Laboratories | 16.55B |
| Macter International | 15.63B |